Daphne Taylor is Senior Vice President and Chief Financial Officer of Aptevo Therapeutics, providing strategic direction to financial operations including audit, tax, accounting, purchasing, treasury, forecasting, budgeting, risk management, and ensuring regulatory compliance. She also oversees Investor Relations, and Information Technology, aligning performance with long-term growth.

Before joining Aptevo, Daphne served as Chief Financial Officer at BioLife Solutions and held senior finance roles at Cardiac Science Corporation, LookSmart, SpeedTrak, Core-Mark International, and Pacific Telesis. She began her career at Coopers & Lybrand in San Francisco. Daphne serves as a leader at Executive Women in Bio (Seattle chapter), holds a B.A. from Sonoma State University and is Certified Public Accountant in Washington and California.